effects [qlco]
Transdermal [ftcn]
Oral [spco]
Estrogen Replacement Therapy [topp]
C-reactive protein level [lbpr]
postmenopausal [tmco]
Women [popg]
placebo-controlled [resa]
Trial [resa]
investigate [ftcn]
postmenopausal [tmco]
Oral [spco]
Transdermal [ftcn]
Hormone Therapy [topp]
Plasma [bdsu]
C-reactive protein [aapp, imft]
Performed [ftcn]
Double-Blind Study [resa]
placebo-controlled [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Received [qlco]
Daily [tmco]
placebo [topp]
N NOS [aapp, imft]
Transdermal [ftcn]
17beta estradiol [horm, phsu, strd]
Te [elii, hops]
Group [idcn]
N NOS [aapp, imft]
Oral [spco]
mg% [qnco]
Oe [qnco]
Group [idcn]
N NOS [aapp, imft]
Oral [spco]
mg% [qnco]
Combined [qlco]
Gestodene [phsu, strd]
Oe [qnco]
Group [idcn]
N NOS [aapp, imft]
treatment [ftcn]
Cycle [tmco]
Cycle [tmco]
placebo [topp]
Group [idcn]
Collected [idcn]
baseline [bodm]
Cycle [tmco]
Cycle [tmco]
C-reactive protein [aapp, imft]
Increased [qnco]
Oe [qnco]
Group [idcn]
Compared [acty]
placebo [topp]
P NOS [aapp, imft]
Percentage [qnco]
baseline [bodm]
placebo [topp]
P NOS [aapp, imft]
Cycle [tmco]
Values [qlco]
Observed [ftcn]
Oe [qnco]
Group [idcn]
Compared [acty]
Cycle [tmco]
placebo [topp]
Group [idcn]
P NOS [aapp, imft]
placebo [topp]
Group [idcn]
Oral [spco]
Increased C-reactive protein [fndg]
larger [qnco]
Oral [spco]
Transdermal [ftcn]
Affect [menp]
C-reactive protein level [lbpr]
